NeuroOne Medical Technologies Corporation Appoints Jason Mills to Board of Directors and Updates Corporate Presentation

2025-12-22SEC Filing 8-K (0001213900-25-124165)

NeuroOne Medical Technologies Corporation announced the appointment of Jason Mills to its Board of Directors, effective December 18, 2025. Mr. Mills, currently Executive Vice President of Strategy at Penumbra, Inc., brings extensive experience in the med-tech industry, including roles in strategic planning, business development, and investor relations, as well as a background as a med-tech investment analyst. He will also serve on the Compensation and Nominating & Corporate Governance Committees. Additionally, on December 22, 2025, the Company posted an updated corporate presentation to its website, which may be used in future communications. This presentation contains forward-looking statements subject to risks and uncertainties.

Ticker mentioned:NMTC